Wednesday, 21 February 2018

Opinion News

  • Healthcare sector responds to Union Budget 2018

    Opinion |  Features | 1 Comment | 03 Feb, 2018

    The last full Budget of the present government played big on its flagship healthcare coverage, which was later dubbed as ‘ModiCare’. This is what the Healthcare sector want...Read more

  • Union Budget 2018: Outlook for Healthcare sector

    Opinion |  Features | 0 Comment | 30 Jan, 2018

    Each year, around the Union Budget, the Healthcare sector eagerly waits for some positive news regarding certain pressing issues, which remain unchanged for decades. Toward this, I sincerel...Read more

  • The ‘Trump’ card

    Opinion |  Views | 0 Comment | 07 Dec, 2017

    There is a blatant contradiction. On one hand, US President Donald Trump recently expressed concern over the prices of prescription drugs going out of control, describing the trend as the &...Read more

  • Virtual healthcare concerns

    Opinion |  Views | 1 Comment | 12 Oct, 2017

    E-commerce is an emerging market place for a large variety of commodities and objects. Going by the rising popularity of e-commerce websites, it is probably the most convenient market place...Read more

  • New era in medicine

    Opinion |  Views | 0 Comment | 14 Sep, 2017

    The US Food & Drug Administration (USFDA) has recently approved the first gene therapy for difficult-to-treat acute lymphoblastic leukemia. The promising medical breakthrough involves g...Read more

  • Overcoming dependency on China...

    Opinion |  Views | 0 Comment | 22 Aug, 2017

    Conflict with China at Doklam is bound to have ripples in different areas, political and economic. Pharma sector is also one of them going by the imports from China for making drugs. Thus, ...Read more

  • Fight on sub-standard drugs

    Opinion |  Views | 0 Comment | 27 Jul, 2017

    India’s Central Drugs Standard Control Organisation (CDSCO), the apex body for regulatory control working under the health ministry, has adopted two prong strategy to control the spre...Read more

  • Is ‘Right-to-try’ bill right?

    Opinion |  Views | 0 Comment | 04 Jul, 2017

    ‘Right-to-try’ is being debated fiercely in US as the American Congress is considering a bill on the topic. It is a practice allowing patients diagnosed with terminal illnesses ...Read more

  • Stent Pricing: A right move

    Opinion |  Views | 0 Comment | 19 May, 2017

    Almost three months after the National Pharmaceutical Pricing Authority (NPPA) ceiling the maximum prices of cardiac stents, as expected, there have been complaints of non-compliance of the...Read more

  • Bionics potential largely untapped in India

    Opinion |  Features | 0 Comment | 27 Apr, 2017

    Artificial limbs that can help people walk, artificial eyes that help blind people see! Who knew that original body parts can be replaced by artificial ones. Welcome to the new world of bio...Read more

  • DermTech announces new pharma collaborations

    Opinion |  News | By BioSpectrum Bureau | 0 Comment | 19 Apr, 2017

    DermTech, Inc., the global leader in non-invasive molecular dermatology, has collaborated with two multi-national pharmaceutical companies. These two recent collaborations are further examp...Read more

Survey Box

Will the world's largest public healthcare scheme work?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls